
$FOLD IPO'd in May 2007 with a valuation of $320M. Bought today for over $4.8B. 15x+ increase in value. But the IPO price was $15.00... and the acquisition price is $14.50. Nearly 95% dilution in 18 years. It's a tough business. That said, if you bought $FOLD in spring of 2014 when times were tough for the company (trading near $2/share), you made 7x return in 11 years... a very healthy return. The ups and downs of biotech.












